STARTUP PROFILE

ElectroCore

COUNTRY
USA
FOUNDED
2005
CATEGORY
Neuromodulation
Developing gammaCore, an FDA-cleared non-invasive vagus nerve stimulation handheld device for the treatment of migraine, cluster headache, and other neurological conditions.
Visit website →
Neurofounders Insights
$   Funding   -
Public
MODALITY
VNS
FORM FACTOR
External device
INTERFACE DEPTH
Non-invasive
INDICATION
Pain/migraine
TARGET USER
Patients
REGULATORY STAGE
FDA cleared (510k)
electroCore is the most commercially advanced non-invasive VNS company, holding the first FDA clearance for neck-based transcutaneous VNS and a broad migraine/cluster headache indication set with reimbursement in some settings. Its public market status and military partnerships give it a distinctive commercial profile in the growing neuromodulation headache space.
Mentioned in Market Notes
MOST RECENT COVERAGE
No items found.
Articles featuring
ElectroCore
No items found.